App-technology to improve lifestyle behaviors among working adults - the Health Integrator study, a randomized controlled trial

Stephanie E Bonn, Marie Löf, Claes-Göran Östenson, Ylva Trolle Lagerros, Stephanie E Bonn, Marie Löf, Claes-Göran Östenson, Ylva Trolle Lagerros

Abstract

Background: Mobile health, mHealth is recognized as a strategy to improve lifestyle behaviors. Research targeting specific lifestyle behaviors has shown that interventions using smartphones can be effective. However, few studies have evaluated solutions with multicomponent interventions, tailoring the intervention to the specific needs of the participant using a combination of mHealth and conventional treatment. To accomplish this, we developed Health Integrator, an mHealth platform with services and offers in the areas of diet, physical activity, sleeping habits, stress, alcohol and tobacco use. In the system, the user selects an area of intervention together with a health coach and set weekly goals. This study protocol presents the design and methodology of the Health Integrator Study, a randomized controlled trial to promote improved lifestyle behaviors.

Methods: A three-arm parallel randomized controlled trial (1:1:1) is conducted in the Stockholm County, Sweden. In total, 209 employees at a four different companies representing both white and blue collar workers, have been recruited. Participants are randomized to either a control group or to one of two intervention groups receiving a 3-month lifestyle behavior change program including either 1) use of Health Integrator and monthly health coaching sessions or 2) only Health Integrator. At baseline and follow-up after 3- and 6-months, all participants answer questionnaires assessing lifestyle behaviors and quality of life. At baseline and the 3-month follow-up (end of intervention period), weight, height, waist circumference and blood pressure are measured, and all participants wear an Actigraph accelerometer for 7 days to assess physical activity. Blood lipid profile and HbA1c are measured among all participants at baseline. If baseline measures fall outside the normal range, a second measurement is done after 3 months.

Discussion: The Health Integrator Intervention Study will evaluate if a personalized intervention combining mHealth and conventional programs for lifestyle change, with or without additional health coach sessions, can improve lifestyle behaviors and quality of life. Based on the results from this trial, Health Integrator can easily be implemented within a broad public.

Trial registration: ClinicalTrials.gov Identifier: NCT03579342 . Retrospectively registered, first submitted May 8, 2018.

Keywords: Adults; Body composition; Exercise; HbA1c; Healthy lifestyle; Metabolic health; Mobile application; Quality of life; Randomized controlled trial; Smartphones.

Conflict of interest statement

Ethics approval and consent to participate

The Health Integrator study was approved by the Regional Ethical Review Board in Stockholm, Sweden on March 21, 2018 (dnr: 2018/411–31) with an amendment on May 28, 2018 (dnr: 2018/1038–32). All study participants received oral and written information about the study. To participate they provided informed consent in connection with the web-based baseline questionnaire, they also signed a second written informed consent at the baseline meeting.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow-chart of the Health Integrator study design
Fig. 2
Fig. 2
Screen shot from the Health Integrator. To the left, the color green indicates that the reported health habit is very good. In the middle, the color yellow indicates that it is good, while orange and red, found to the right, indicate that the health habit is unhealthy, can be improved, and should be targeted in the intervention

References

    1. Schroeder SA, Shattuck Lecture We can do better--improving the health of the American people. N Engl J Med. 2007;357(12):1221–1228. doi: 10.1056/NEJMsa073350.
    1. WHO. mHealth: New horizons for health through mobile technologies: second global survey on eHealth.; 2011.
    1. Silva BM, Rodrigues JJ, de la Torre Diez I, Lopez-Coronado M, Saleem K. Mobile-health: a review of current state in 2015. J Biomed Inform. 2015;56:265–272. doi: 10.1016/j.jbi.2015.06.003.
    1. The Swedes and Internet 2018 (Svenskarna och internet 2018). Accessed 22, Nov 2018 available from: .
    1. Burton J. WHO Healthy workplace framework: background and supporting literature and practices.: WHO headquarters, Geneva, Switzerland 2010.
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Eysenbach G. CONSORT-EHEALTH: implementation of a checklist for authors and editors to improve reporting of web-based and mobile randomized controlled trials. Stud Health Technol Inform. 2013;192:657–661.
    1. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40(1):78–89. doi: 10.1515/CCLM.2002.016.
    1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–475.
    1. Lintsi M, Kaarma H, Kull I. Comparison of hand-to-hand bioimpedance and anthropometry equations versus dual-energy X-ray absorptiometry for the assessment of body fat percentage in 17-18-year-old conscripts. Clin Physiol Funct Imaging. 2004;24(2):85–90. doi: 10.1111/j.1475-097X.2004.00534.x.
    1. Lee JA, Williams SM, Brown DD, Laurson KR. Concurrent validation of the Actigraph gt3x+, polar active accelerometer, Omron HJ-720 and Yamax Digiwalker SW-701 pedometer step counts in lab-based and free-living settings. J Sports Sci. 2015;33(10):991–1000. doi: 10.1080/02640414.2014.981848.
    1. Meyer U, Ernst D, Schott S, Riera C, Hattendorf J, Romkes J, et al. Validation of two accelerometers to determine mechanical loading of physical activities in children. J Sports Sci. 2015;33(16):1702–9.
    1. Martin E, Ruf E, Landgraf R, Hauner H, Weinauer F, Martin S. FINDRISK questionnaire combined with HbA1c testing as a potential screening strategy for undiagnosed diabetes in a healthy population. Horm Metab Res. 2011;43(11):782–787. doi: 10.1055/s-0031-1286333.
    1. Westerlund A, Lagerros YT, Kecklund G, Axelsson J, Akerstedt T. Relationships between questionnaire ratings of sleep quality and polysomnography in healthy adults. Behav Sleep Med. 2016;14(2):185–199. doi: 10.1080/15402002.2014.974181.
    1. Messerer M, Johansson SE, Wolk A. The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr. 2004;134(7):1800–1805. doi: 10.1093/jn/134.7.1800.
    1. Sepp H, Becker W. Enkätfrågor om kost och fysisk aktivitet bland vuxna – Underlag till urval av frågor i befolkningsinriktade enkäter. [Swedish] The National Food Agency, Sweden. 2004.
    1. Karlsson J, Persson LO, Sjostrom L, Sullivan M. Psychometric properties and factor structure of the three-factor eating questionnaire (TFEQ) in obese men and women. Results from the Swedish obese subjects (SOS) study. Int J Obes Relat Metab Disord. 2000;24(12):1715–1725. doi: 10.1038/sj.ijo.0801442.
    1. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350–357. doi: 10.3109/07853890109002089.
    1. Scheier MF, Wrosch C, Baum A, Cohen S, Martire LM, Matthews KA, et al. The life engagement test: assessing purpose in life. J Behav Med. 2006;29(3):291–298. doi: 10.1007/s10865-005-9044-1.
    1. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–396. doi: 10.2307/2136404.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48. doi: 10.4278/0890-1171-12.1.38.
    1. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–651. doi: 10.1056/NEJMoa1600869.
    1. WHO. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. 2013.
    1. Schoeppe S, Alley S, Van Lippevelde W, Bray NA, Williams SL, Duncan MJ, et al. Efficacy of interventions that use apps to improve diet, physical activity and sedentary behaviour: a systematic review. Int J Behav Nutr Phys Act. 2016;13(1):127. doi: 10.1186/s12966-016-0454-y.
    1. Zarski AC, Lehr D, Berking M, Riper H, Cuijpers P, Ebert DD. Adherence to internet-based Mobile-supported stress management: a pooled analysis of individual participant data from three randomized controlled trials. J Med Internet Res. 2016;18(6):e146. doi: 10.2196/jmir.4493.
    1. Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21):1959–1968. doi: 10.1056/NEJMoa1108660.
    1. Robertson L, Smith M, Castle D, Tannenbaum D. Using the internet to enhance the treatment of depression. Australas Psychiatry. 2006;14(4):413–417. doi: 10.1111/j.1440-1665.2006.02315.x.
    1. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95. doi: 10.1007/s12160-013-9486-6.
    1. Davidsson P. The Swedes and Internet 2017 (Svenskarna och internet 2017) Accessed 8, Nov 2018 available from: .

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi